Helvetica Chimica Acta Vol. 85 (2002)
1483
1',4'-Anhydro-2',5'-dideoxy-6'-O-(4,4'-dimethoxytriphenylmethyl)-2'-(thymin-1-yl)-d-altritol (5). Com-
pound 4 (300 mg, 1.17 mmol) was dissolved in anh. pyridine (20 ml), then dimethoxytrityl chloride (477 mg,
1.40 mmol) was added under stirring with ice-water cooling. The soln. was stirred at r.t. for 24 h. After
evaporation, the mixture was purified by CC (silica gel, AcOEt/CHCl3/Et3N 7:2 :1: 5 (640 mg, 97.8%). 1H-NMR
((D6)DMSO): 1.75 (s, MeÀC(5)); 1.95 (m, 2 HÀC(5')); 3.05 (t, J 6.6, 2 HÀC(6')); 3.63 (m, HÀC(4')); 3.72
(s, 2 MeO); 3.74 (d, J 7.5, 2 HÀC(1')); 3.91 (t, J 8.9, HÀC(3')); 4.76 (m, HÀC(2')); 6.86 7.40 (m, 14 ar-
om. H). FAB-MS: 559 ([M H] ).
1'4'-Anhydro-2',5'-didehydro-6'-O-(4,4'-dimethoxytriphenylmethyl)-2'-(thymin-1-yl)-d-altritol 3'-O-(2-Cya-
noethyl) Diisopropylphosphoramidite (6). To a soln. of 5 (477 mg, 0.877 mmol) in anh. THF (7.0 ml), iPr2EtN
(0.5 ml, 2.85 mmol) was added under Ar. To this soln., 2-cyanoethyl diisopropyl phosphoramidochloridite
(0.46 ml, 1.9 mmol) was added slowly under ice-water cooling. After stirring at 08 for 10 min and at r.t. for
30 min, the mixture was quenched by addition of MeOH (1 ml). After stirring for 10 min, AcOEt (20 ml) was
added, the org. layer washed twice with 5% aq. NaHCO3 soln. (5.0 ml) followed by H2O (5 ml), dried (Na2SO4),
and evaporated, and the oily residue purified by CC (silica gel, petroleum ether/AcOEt/CH2Cl2 2 :1:1 (1%
Et3N)): 6 (649 mg, 96%). Colorless foam. 31P-NMR ((D6)DMSO): 150.7.
Solid-Phase Synthesis of Oligonucleotide 7. Oligonucleotide synthesis was carried out on a 1-mm scale with a
DNA synthesizer (model 391A; Applied Biosystems) applying regular phosphoramidite chemistry (DMT off).
Cleavage and deprotection of the oligonucleotide were performed in conc. aq. ammonia soln. at 508 for 24 h.
The oligomer was purified by HPLC (ZOBAX Oligo semi-prep. column (9.4 mm  250 mm), gradient elution
with eluants A (MeCN/0.02m NaH2PO4 1:4) and B (1.0m NaCl in eluant A), flow rate 1.0 ml/min). The product-
containing fraction was desalted by means of a Sephadex-G-15 column. The pure oligonucleotide was
lyophilized and stored at À208. Total incorporation yield: 66%. MALDI-TOF-MS: 4368.88 (calc. 4365.06).
Enzymatic Stability of Oligonucleotide 7. Oligonucleotide 7 (0.2 OD) in 1.0 ml of buffer soln. (0.1m, NaCl,
0.14 mm MgCl2, 0.1m Tris ¥ HCl, pH 8.6) was digested with 1.2 U of SVPDE at 378. During digestion, the increase
in absorbance at 260 nm was followed. The absorption vs. time curve of the digestion was plotted and the
hyperchromicity evaluated.
UV Melting Experiments. UV Melting experiments were recorded with a Pharmacia-LKB-Biochrom-4060
spectrophotometer. Oligomers were dissolved in a buffer soln. containing 0.14m NaCl, 0.01m Na2HPO4, 1.0 mm
EDTA (pH 7.2). The soln. containing oligonucleotide 7 at a concentration of 2 mm was mixed with an equimolar
amount of dA14 or equimolar per nucleotide amount of polyA. Samples were incubated at 808 for 5 min, slowly
cooled to 48, and kept at this temp. overnight. These samples were used for the thermal denaturation studies.
Thermally induced transitions of every mixture were monitored at 260 nm. Sample temp. was increased at 0.28/
min between 15 and 758.
CDSpectra . CD Spectra were measured at 208 with a J715 CD spectrophotometer (JAC) in thermostati-
cally controlled 1-cm cuvettes. The oligomers were dissolved and analyzed in buffer containing 10 mm
Na2HPO4, 0.14m NaCl, and 1.0 mm EDTA (pH 7.2), and at a oligonucleotide concentration of 4 mm or
equimolar per nucleotide amount.
The project was supported by the National Natural Science Foundation of China and the Ministry of Science
and Technology of China (G1998051103).
REFERENCES
[1] C. A. Stein, J. Tonkinson, L. Yakubov, Pharmacol. Ther. 1991, 52, 365.
[2] W. S. Marshall, M. H. Caruthers, Science (Washington, D.C.) 1993, 259, 1564.
[3] F. Debart, B. Rayner, G. Degols, J.-L. Imbach, Nucleic Acids Res. 1992, 20, 1193.
[4] B. S. Sproat, B. Beijer, A. Iribarren, Nucleic Acids Res. 1990, 18, 41.
[5] J. Sagi, J. Szemzo, J. Szecsi, L. Otvos, Nucleic Acids Res. 1990, 18, 2133.
[6] J. Nemunaitis, J. T. Holmlund, M. Kraynak, D. Richards, J. Bruce, N. Ognoskie, T. J. Kwoh, R. Geary, A.
Dorr, D. von Hoff, S. G. Eckhardt, J. Clin. Oncol. 1999, 17, 3586.
[7] K. Augustyns, F. Vandendriesshe, A. van Aerschot, R. Busson, C. Urbanke, P. Herdewijn, Nucleic Acids
Res. 1992, 20, 4711.
[8] J. Wengel, A. Koshkin, K. S. Singh, P. Nielson, M. Meldgaard, V. K. Rajwanshi, R. Kumar, J. Skour, C. B.
Nielson, J. P. Jacobsen, N. Jacobsen, C. E. Olsen, Nucleosides Nucleotides 1999, 18, 1365.
[9] H. W. Yu, L. R. Zhang, L. T. Ma, L. H. Zhang, Bioorg. Med. Chem. 1996, 4, 609.
[10] H. W. Yu, H. Y. Zhang, Z. J. Yang, J. M. Min, L. T. Ma, L. H. Zhang, Pure Appl. Chem. 1998, 70, 435.